About Us
Sedana Medical is a Swedish medical technology company that was founded in 2005 after acquiring the AnaConDa from Teleflex. The AnaConDa technology was originally developed by Louis Gibeck AB, a leader in heat and moisture exchangers. Our headquarters are based in Danderyd outside Stockholm in Sweden and in Ireland, where the company has its headquarters for R&D. The company’s business includes the development, marketing and sale of medical devices and drug development for future projects around AnaConDa. The AnaConDa enables simple delivery of volatile anaesthetics to invasively ventilated patients. The company’s product range includes AnaConDa and AnaConDa-S with relevant accessories.
Company History
2019
Iso-COMFORT pediatrics study begins
2019
AnaConDa approved for use on children in the EU
2019
Registration process in the USA begins
2019
Distribution agreements concluded in India and China
2018
Health-economics study shows the benefits of AnaConDa
2018
AnaConDa receives market approval in Japan
2018
Opens own sales offices in the United Kingdom and the Nordics
2017
Company launches on the Nasdaq First North stock exchange
2017
New Head Quarters office opened in Stockholm Sweden
2017
New AnaConDa-S launched in Europe
2017
KFDA approve AnaConDa in South Korea
2017
Christer Ahlberg appointed as new CEO
2016
Decision made to invest in a clinical study in Germany leading to Market Authorization of sedation in the ICU in Europe
2016
Over 200,000 devices used since launch
2015
Study finds that one year mortality is significantly lower in isoflurane vs. IV sedated patients
2014
AnaConDa now being used in Canada, Australia most of Europe
2013
New R&D office opened in Kildare Ireland
2012
New Office Sales office opened in Madrid Spain
2008
Study shows that short-term sevoflurane sedation using AnaConDa after cardiothoracic surgery significantly reduces ventilation time and hospital stay
2007
Sedana establishes test market in Germany
2005
Sedana Medical office opens in Germany
2005
Sedana Medical Founded In Uppsala Sweden
1999
AnaConDa first used in Sweden in the mid 90's and tested in a clinical setting for the first time
Management
Jens Lindberg
Interim CEO &
Vice President
Commercial Operations
Susanne Andersson
CFO
Sylvia Buddenbaum Eriksson
HR director
Robert vom Dorp
Vice President
Business Development
Peter Fröberg
Chief Technology Officer
Stefan Krisch
Supply Chain &
Manufacturing Director
Peter Sackey
CMO
Jessica Westfal
Vice President
Regulatory Affairs & QA
Board
Thomas Eklund
Chairman
Claus Bjerre
Board Member &
Vice Chairman
Bengt Julander
Board Member
Ola Magnusson
Board Member
Eva Walde
Board Member
